April 11, 2013 Aptalis Pharma(TM) Launches PYLERA(R) in France: A Therapeutic Alternative for Eradicating Helicobacter Pylori and Preventing Relapse of H. Pylori Associated Peptic Ulcers
January 07, 2013 Aptalis Pharma, Inc. Announces Results of Phase 3 Studies of Aeroquin(TM) (Levofloxacin Solution for Inhalation) Among Patients With Cystic Fibrosis and Chronic Lung Infection
Steve Gannon Senior Vice President, Chief Financial Officer and Treasurer
Aptalis 597, Laurier Blvd. Mont-Saint-Hilaire, QC, J3H 6C4 Canada
Tel: (450) 467-2600 or 1 (877) 982-2600 ext. 2442 Fax: (450) 464-9979 E-mail: Steve Gannon